Literature DB >> 1374778

Expression of functional antigens on neutrophils. Effects of preparation.

M G Macey1, X P Jiang, P Veys, D McCarthy, A C Newland.   

Abstract

We have studied how different conditions of cell labelling and isolation affect the expression of five functional antigens on neutrophils from healthy subjects. Fluorescein isothiocyanate conjugated (FITC) antisera specific for the C3bi receptor CR3 (CD11b), aminopeptidase N (CD13), the LPS:LPS binding protein receptor (CD14) and the receptors for human IgG (Fc gamma RII CDw32 and Fc gamma RIII CD16) were incubated with (i) unfixed whole blood at 4 degrees C and at room temperature (RT, approximately 20 degrees C), and the leukocytes prepared for analysis using the Coulter Q-Prep system, (ii) leukocytes which had obtained following the removal of erythrocytes from whole blood by dextran sedimentation and which had been washed or left unwashed at RT, and (iii) leukocytes which had been prepared from whole blood that had been formaldehyde fixed immediately following venesection. The amount of fluorescence associated with the cells was determined by flow cytometry. The expression of CD14 was low under all conditions. However the expression of CD11b, CD16 and CDw32 was significantly higher (p less than 0.05) on neutrophils obtained by dextran sedimentation (n = 4) than on cells which had been fixed with formaldehyde ex vivo; the increase in expression was even greater if the cells had been washed. In contrast, the expression of CD13 on formaldehyde fixed cells was higher than on cells which had been labelled at 4 degrees C or at room temperature and was similar to or slightly lower than that on cells obtained by dextran sedimentation. Increasing the time between 10 and 60 min for which the whole blood was incubated with antisera at RT or at 4 degrees C, resulted in progressive increases in the expression of CD11b and CD13. When neutrophils which had been obtained by dextran sedimentation were incubated with unlabelled antibodies to CD16 or CDw32 and FITC labelled antibodies to CD11b there was a marked increase in the expression of CD11b. Altogether these findings indicate that the analysis of functional molecules on neutrophils (which may be rapidly up-regulated during activation) should be performed under clearly defined and controlled conditions. Dual fluorescence studies may, in some circumstances, produce misleading results.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374778     DOI: 10.1016/s0022-1759(12)80046-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  6 in total

1.  Neutrophil isolation from nonhuman species.

Authors:  Daniel W Siemsen; Natalia Malachowa; Igor A Schepetkin; Adeline R Whitney; Liliya N Kirpotina; Benfang Lei; Frank R Deleo; Mark T Quinn
Journal:  Methods Mol Biol       Date:  2014

2.  Assessment of neutrophil function in patients with septic shock: comparison of methods.

Authors:  C Wenisch; P Fladerer; S Patruta; R Krause; W Hörl
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

3.  Are circulating neutrophils intravascularly activated in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides?

Authors:  A C Muller Kobold; G Mesander; C A Stegeman; C G Kallenberg; J W Tervaert
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

4.  Leukocyte activation and function-associated antigens in inflammatory disease.

Authors:  M G Macey; J M Wilton; R Carbon; S Edmonds; J D Perry; D McCarthy
Journal:  Agents Actions       Date:  1993

5.  The Application of Dextran Sedimentation as an Initial Step in Neutrophil Purification Promotes Their Stimulation, due to the Presence of Monocytes.

Authors:  Alex Quach; Antonio Ferrante
Journal:  J Immunol Res       Date:  2017-10-15       Impact factor: 4.818

6.  Investigation of the response of tear-film neutrophils to interleukin 8 and their sensitivity to centrifugation, fixation, and incubation.

Authors:  Yutong Jin; Lyndon Jones; Maud Gorbet
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.